MX388708B - Vacunas recombinantes contra fmdv y sus usos. - Google Patents

Vacunas recombinantes contra fmdv y sus usos.

Info

Publication number
MX388708B
MX388708B MX2017003712A MX2017003712A MX388708B MX 388708 B MX388708 B MX 388708B MX 2017003712 A MX2017003712 A MX 2017003712A MX 2017003712 A MX2017003712 A MX 2017003712A MX 388708 B MX388708 B MX 388708B
Authority
MX
Mexico
Prior art keywords
fmdv
vaccine
vaccines
recombinant fmdv
fmdv vaccines
Prior art date
Application number
MX2017003712A
Other languages
English (en)
Other versions
MX2017003712A (es
Inventor
Frederic Reynard
Jean-Christophe Audonnet
Justin Widener
Teshome Mebatsion
Yu- Wei Chiang
Zahia Hannas-Djebbara
Original Assignee
Boehringer Ingelheim Animal Health Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc
Publication of MX2017003712A publication Critical patent/MX2017003712A/es
Publication of MX388708B publication Critical patent/MX388708B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a vacunas o composiciones contra FMDV. La vacuna o composición puede ser una vacuna o composición que contiene antígenos FMDV. La invención también abarca vectores recombinantes que codifican y que expresan antígenos FMDV, epítopos o inmunógenos que se pueden utilizar para proteger animales, en particular ovinos, bovinos, caprinos o porcinos, contra FMDV.
MX2017003712A 2014-09-23 2015-09-23 Vacunas recombinantes contra fmdv y sus usos. MX388708B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462054073P 2014-09-23 2014-09-23
PCT/US2015/051755 WO2016049209A1 (en) 2014-09-23 2015-09-23 Fmdv recombinant vaccines and uses thereof

Publications (2)

Publication Number Publication Date
MX2017003712A MX2017003712A (es) 2017-06-28
MX388708B true MX388708B (es) 2025-03-20

Family

ID=54256845

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003712A MX388708B (es) 2014-09-23 2015-09-23 Vacunas recombinantes contra fmdv y sus usos.

Country Status (16)

Country Link
US (1) US10010605B2 (es)
EP (1) EP3197486A1 (es)
JP (1) JP6931327B2 (es)
KR (1) KR102526219B1 (es)
CN (1) CN107073100B (es)
AP (1) AP2017009834A0 (es)
AR (1) AR102006A1 (es)
AU (2) AU2015320673B2 (es)
CA (1) CA2962225A1 (es)
JO (1) JO3600B1 (es)
MA (1) MA40151B2 (es)
MX (1) MX388708B (es)
RU (1) RU2745373C2 (es)
TW (1) TWI733653B (es)
WO (1) WO2016049209A1 (es)
ZA (1) ZA201701851B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391163B2 (en) 2015-09-10 2019-08-27 Academia Sinica Bird flu vaccine combination comprising virus-like particles and novel adjuvants
CN108367067B (zh) 2015-11-23 2022-05-03 勃林格殷格翰动物保健美国公司 Fmdv和e2的融合蛋白质及其用途
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
US10172933B2 (en) 2016-10-31 2019-01-08 The United States Of America, As Represented By The Secretary Of Agriculture Mosaic vaccines for serotype a foot-and-mouth disease virus
CA3068052A1 (en) * 2017-07-12 2019-01-17 Boheringer Ingelheim Animal Health Usa Inc. Senecavirus a immunogenic compositions and methods thereof
CN108103034B (zh) * 2017-12-15 2022-06-24 云南农业大学动物医学院 同时表达A型、O型和Asia-1型口蹄疫病毒VP1基因重组腺病毒、构建方法及应用
CN108530522B (zh) * 2018-03-14 2021-09-17 中华人民共和国汕头海关 一种重组的OmpK多表位多肽、构建方法及其应用
CN110467654B (zh) * 2018-05-11 2022-08-09 普莱柯生物工程股份有限公司 口蹄疫病毒样颗粒抗原、其制备的疫苗组合物及其制备方法和应用
CN111233984B (zh) * 2018-11-29 2022-08-12 普莱柯生物工程股份有限公司 一种o型口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用
WO2020147015A1 (zh) * 2019-01-15 2020-07-23 普莱柯生物工程股份有限公司 口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用
CN114423779B (zh) * 2019-06-28 2024-07-02 株式会社准绳生命科学 口蹄疫病毒疫苗组合物
AR123873A1 (es) * 2020-10-22 2023-01-18 Intervet Int Bv Vector de expresión de baculovirus
AU2021363613A1 (en) * 2020-10-22 2023-05-11 Intervet International B.V. Baculovirus expression vector
US12453767B2 (en) 2021-08-18 2025-10-28 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype O
WO2023020737A1 (en) * 2021-08-20 2023-02-23 Intervet International B.V. Fmdv virus-like particle with stabilizing mutation
EP4387663A1 (en) * 2021-08-20 2024-06-26 Intervet International B.V. Method of producing a foot and mouth disease virus virus-like particle
IL310905A (en) * 2021-08-20 2024-04-01 Intervet Int Bv A method for producing a virus-like particle for foot-and-mouth disease virus
EP4387665A1 (en) * 2021-08-20 2024-06-26 The Pirbright Institute Fmdv virus-like particle with double stabilizing mutation
KR102513632B1 (ko) * 2021-11-30 2023-03-28 주식회사 왓슨알앤디 구제역 바이러스 유사 입자를 생산하기 위한 백신 플랫폼
US12036318B2 (en) * 2022-02-16 2024-07-16 Chemical & Schutz High Performance Lubricants, S.A. De C.V. Self-emulsionable mineral oil as a vehicle in vaccines for poultry
JP2025538585A (ja) * 2022-11-23 2025-11-28 オプティファーム カンパニー リミテッド 口蹄疫ウィルス様粒子またはナノ粒子生産のための組換え発現ベクターおよびこれを用いたワクチン組成物
KR20240087552A (ko) 2022-11-23 2024-06-19 주식회사 옵티팜 구제역 바이러스 유사 입자 또는 나노입자 생산을 위한 재조합 발현 벡터 및 이를 이용한 백신 조성물
CN117210501B (zh) * 2023-09-13 2024-06-07 中国农业科学院兰州兽医研究所 口蹄疫病毒2b蛋白免疫抑制位点突变的重组口蹄疫病毒株的构建
CN117304277B (zh) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用
US20250134984A1 (en) * 2023-10-26 2025-05-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype asia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
FR2810888B1 (fr) * 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
PL1773387T3 (pl) * 2004-06-25 2013-10-31 Merial Inc Rekombinanty wirusa ospy ptasiej wyrażające geny wirusa pryszczycy
BRPI0618441B8 (pt) 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral
JP5309159B2 (ja) * 2008-01-09 2013-10-09 コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション バキュロウイルスを利用したワクチン
CN101270155B (zh) * 2008-05-06 2011-04-27 中国农业科学院兰州兽医研究所 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法
GB0810710D0 (en) * 2008-06-11 2008-07-16 Animal Health Inst Vaccine
NZ702145A (en) * 2010-03-12 2016-03-31 Merial Inc Bluetongue virus recombinant vaccines and uses thereof
WO2012158613A1 (en) * 2011-05-13 2012-11-22 Novartis Ag Pre-fusion rsv f antigens
GB201111183D0 (en) * 2011-06-30 2011-08-17 Animal Health Inst Peptide
US20150183835A1 (en) * 2012-06-18 2015-07-02 Novartis Ag Stabilized gp120
US9738689B2 (en) * 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use

Also Published As

Publication number Publication date
BR112017005833A8 (pt) 2023-02-14
CA2962225A1 (en) 2016-03-31
AP2017009834A0 (en) 2017-03-31
AU2019210537A1 (en) 2019-08-15
CN107073100A (zh) 2017-08-18
BR112017005833A2 (pt) 2018-02-27
JP2017530124A (ja) 2017-10-12
TWI733653B (zh) 2021-07-21
US20160220659A1 (en) 2016-08-04
RU2017113571A3 (es) 2019-04-22
WO2016049209A1 (en) 2016-03-31
MA40151A1 (fr) 2018-01-31
JP6931327B2 (ja) 2021-09-01
EP3197486A1 (en) 2017-08-02
KR20170058430A (ko) 2017-05-26
JO3600B1 (ar) 2020-07-05
AR102006A1 (es) 2017-01-25
AU2015320673B2 (en) 2019-05-02
RU2017113571A (ru) 2018-10-26
CN107073100B (zh) 2021-02-26
TW201625297A (zh) 2016-07-16
AU2015320673A1 (en) 2017-05-11
MX2017003712A (es) 2017-06-28
KR102526219B1 (ko) 2023-04-26
MA40151B2 (fr) 2022-12-30
ZA201701851B (en) 2018-05-30
US10010605B2 (en) 2018-07-03
RU2745373C2 (ru) 2021-03-24

Similar Documents

Publication Publication Date Title
MX388708B (es) Vacunas recombinantes contra fmdv y sus usos.
NZ602278A (en) Bluetongue virus recombinant vaccines and uses thereof
NZ744786A (en) Recombinant adenovirus vectored fmdv vaccines and uses thereof
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
IL257800A (en) Immune compositions with improved stability and immunogenicity
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
DK3570879T3 (da) Immunogene sammensætninger til anvendelse i pneumokokvacciner
MX382535B (es) Proteinas de fusion fmdv y e2 y usos de ellos.
DK3244917T5 (da) Immunogene sammensætninger til anvendelse i pneumokokvacciner
DK3096785T3 (da) Immunogene sammensætninger omfattende konjugerede kapsel-saccharid-antigener og anvendelser deraf
ZA201701000B (en) Attenuated bovine coronavirus and related vaccines
MX2017005687A (es) Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
EP3439693A4 (en) NEW PNEUMOCOCCAL VACCINE FORMULATIONS
PT3498850T (pt) Cassete de expressão heteróloga, construção de dna e composição de vacina para imunização contra flavivírus e/ou outros patogénios
PH12018500372B1 (en) Fcv recombinant vaccines and uses thereof
MX2018003173A (es) Vacunas de salmonella choleraesuis-salmonella typhimurium.
NZ734938A (en) Leptospira immunoprotective proteins and methods of identification and use thereof
UY36328A (es) Vacunas de fmdv recombinante y usos de las mismas
MX390292B (es) Vacuna heterologa atenuada viva para leptospira.
TH1601001639A (th) องค์ประกอบวัคซีนของ pcv2b แบบไดเวอร์เจนท์ และวิธีการใช้งาน